Yosuke Nakatani, Thomas Pambrun, Takashi Nakashima, Masateru Takigawa, F Daniel Ramirez, Cyril Goujeau, Clémentine André, Konstantinos Vlachos, Aline Carapezzi, Ghassen Cheniti, Romain Tixier, Remi Chauvel, Josselin Duchateau, Frédéric Sacher, Meleze Hocini, Michel Haïssaguerre, Pierre Jaïs, Nicolas Derval
{"title":"心动过速回路中累及冠状窦的局部再入性房性心动过速的特点。","authors":"Yosuke Nakatani, Thomas Pambrun, Takashi Nakashima, Masateru Takigawa, F Daniel Ramirez, Cyril Goujeau, Clémentine André, Konstantinos Vlachos, Aline Carapezzi, Ghassen Cheniti, Romain Tixier, Remi Chauvel, Josselin Duchateau, Frédéric Sacher, Meleze Hocini, Michel Haïssaguerre, Pierre Jaïs, Nicolas Derval","doi":"10.1016/j.jacep.2025.07.029","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Localized-re-entrant atrial tachycardias (ATs) involving the coronary sinus (CS) as a critical part of the circuit (CS-ATs) remain poorly characterized.</p><p><strong>Objectives: </strong>The goal of this study was to determine the prevalence, clinical characteristics, and electrophysiological properties of CS-ATs.</p><p><strong>Methods: </strong>CS-ATs were identified in a cohort of 545 consecutive patients with 775 ATs mapped by using a high-density mapping system.</p><p><strong>Results: </strong>Eight CS-ATs (1.0% of all ATs; 95% CI: 0.5%-2.0%) were identified in 8 patients (1.5% of all patients; 95% CI: 0.7%-2.9%). All had prior ablation in the inferior septum, bottom wall of the left atrium (LA), or CS, resulting in scar formation in either the inferior septum or bottom wall in 6 patients (75%). The mean tachycardia cycle length was 299 ± 70 milliseconds. The CS segment involved in the tachycardia circuit measured 28 ± 11 mm in length, with a conduction time of 58 ± 31 milliseconds (21% ± 13% of tachycardia cycle length). All CS-ATs exhibited a centrifugal activation pattern originating from the inferior part of the LA. CS-ATs were correctly diagnosed in only 2 patients. Ablation targeting the LA-CS connection successfully terminated CS-AT in 4 patients, and ethanol infusion into the vein of Marshall was required in 3 patients. CS-AT could not be terminated in 1 patient because of an inappropriate ablation strategy.</p><p><strong>Conclusions: </strong>CS-ATs are a rare cause of AT, typically occurring after ablation in the inferior part of the LA or CS. Diagnosing CS-ATs can be challenging. Ablation targeting the LA-CS connection is effective, and ethanol infusion into the vein of Marshall is a viable therapeutic option.</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characteristics of Localized Re-Entrant Atrial Tachycardia Involving the Coronary Sinus in the Tachycardia Circuit.\",\"authors\":\"Yosuke Nakatani, Thomas Pambrun, Takashi Nakashima, Masateru Takigawa, F Daniel Ramirez, Cyril Goujeau, Clémentine André, Konstantinos Vlachos, Aline Carapezzi, Ghassen Cheniti, Romain Tixier, Remi Chauvel, Josselin Duchateau, Frédéric Sacher, Meleze Hocini, Michel Haïssaguerre, Pierre Jaïs, Nicolas Derval\",\"doi\":\"10.1016/j.jacep.2025.07.029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Localized-re-entrant atrial tachycardias (ATs) involving the coronary sinus (CS) as a critical part of the circuit (CS-ATs) remain poorly characterized.</p><p><strong>Objectives: </strong>The goal of this study was to determine the prevalence, clinical characteristics, and electrophysiological properties of CS-ATs.</p><p><strong>Methods: </strong>CS-ATs were identified in a cohort of 545 consecutive patients with 775 ATs mapped by using a high-density mapping system.</p><p><strong>Results: </strong>Eight CS-ATs (1.0% of all ATs; 95% CI: 0.5%-2.0%) were identified in 8 patients (1.5% of all patients; 95% CI: 0.7%-2.9%). All had prior ablation in the inferior septum, bottom wall of the left atrium (LA), or CS, resulting in scar formation in either the inferior septum or bottom wall in 6 patients (75%). The mean tachycardia cycle length was 299 ± 70 milliseconds. The CS segment involved in the tachycardia circuit measured 28 ± 11 mm in length, with a conduction time of 58 ± 31 milliseconds (21% ± 13% of tachycardia cycle length). All CS-ATs exhibited a centrifugal activation pattern originating from the inferior part of the LA. CS-ATs were correctly diagnosed in only 2 patients. Ablation targeting the LA-CS connection successfully terminated CS-AT in 4 patients, and ethanol infusion into the vein of Marshall was required in 3 patients. CS-AT could not be terminated in 1 patient because of an inappropriate ablation strategy.</p><p><strong>Conclusions: </strong>CS-ATs are a rare cause of AT, typically occurring after ablation in the inferior part of the LA or CS. Diagnosing CS-ATs can be challenging. Ablation targeting the LA-CS connection is effective, and ethanol infusion into the vein of Marshall is a viable therapeutic option.</p>\",\"PeriodicalId\":14573,\"journal\":{\"name\":\"JACC. Clinical electrophysiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":7.7000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Clinical electrophysiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jacep.2025.07.029\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Clinical electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacep.2025.07.029","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Characteristics of Localized Re-Entrant Atrial Tachycardia Involving the Coronary Sinus in the Tachycardia Circuit.
Background: Localized-re-entrant atrial tachycardias (ATs) involving the coronary sinus (CS) as a critical part of the circuit (CS-ATs) remain poorly characterized.
Objectives: The goal of this study was to determine the prevalence, clinical characteristics, and electrophysiological properties of CS-ATs.
Methods: CS-ATs were identified in a cohort of 545 consecutive patients with 775 ATs mapped by using a high-density mapping system.
Results: Eight CS-ATs (1.0% of all ATs; 95% CI: 0.5%-2.0%) were identified in 8 patients (1.5% of all patients; 95% CI: 0.7%-2.9%). All had prior ablation in the inferior septum, bottom wall of the left atrium (LA), or CS, resulting in scar formation in either the inferior septum or bottom wall in 6 patients (75%). The mean tachycardia cycle length was 299 ± 70 milliseconds. The CS segment involved in the tachycardia circuit measured 28 ± 11 mm in length, with a conduction time of 58 ± 31 milliseconds (21% ± 13% of tachycardia cycle length). All CS-ATs exhibited a centrifugal activation pattern originating from the inferior part of the LA. CS-ATs were correctly diagnosed in only 2 patients. Ablation targeting the LA-CS connection successfully terminated CS-AT in 4 patients, and ethanol infusion into the vein of Marshall was required in 3 patients. CS-AT could not be terminated in 1 patient because of an inappropriate ablation strategy.
Conclusions: CS-ATs are a rare cause of AT, typically occurring after ablation in the inferior part of the LA or CS. Diagnosing CS-ATs can be challenging. Ablation targeting the LA-CS connection is effective, and ethanol infusion into the vein of Marshall is a viable therapeutic option.
期刊介绍:
JACC: Clinical Electrophysiology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC). It encompasses all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. Submissions of original research and state-of-the-art reviews from cardiology, cardiovascular surgery, neurology, outcomes research, and related fields are encouraged. Experimental and preclinical work that directly relates to diagnostic or therapeutic interventions are also encouraged. In general, case reports will not be considered for publication.